Ceapro Inc. (CRPOF) Stock

About Ceapro Inc.

Operating as a biotechnology enterprise, Ceapro Inc. is dedicated to pioneering and bringing to market health and wellness offerings, alongside their underlying technologies, which are all predicated on plant-derived compounds. Its commercial reach extends across the United States, Germany, China, Canada, and various other global markets. The company's operations are divided into two principal sectors. The first, its Active Ingredient Product Technology division, is centered on inventing and employing exclusive extraction methodologies. These are utilized for the manufacturing, refinement, and sale of potent substances like oat beta glucan and avenanthramides, extracted from oats and other sustainable botanical sources, serving both the healthcare and beauty industries. Conversely, the Cosmeceutical Industry segment concentrates on the creation and commercial release of anti-aging goods. These products, formulated from natural active components, are primarily distributed straight to consumers through the company's online portal and via a network of specialized natural product retailers. Established in 1997, Ceapro Inc.'s main corporate office is located in Edmonton, Canada.

Ceapro Inc. is headquartered in CA.

Ceapro Inc. (CRPOF) stock trades at $0.17 with a market capitalization of $13.31M. The stock is valued at a price-to-earnings (P/E) ratio of -3.74, price-to-book of 0.63, price-to-sales of 0.07. Over the past 52 weeks the stock has ranged between $0.12 and $0.40, and currently trades 57.5% below its 52-week high.

On profitability, Ceapro Inc. generates a return on equity (ROE) of -15.66%, return on capital employed of -21.06%, an operating margin of -64.93%, a net profit margin of -48.89%.

Official website: www.ceapro.com